4369 · Tri Chemical Laboratories Inc. · Financials
Market Cap
95.44B JPY
Shares
32.50M
Volume · Nov 11
483.5K
Avg daily vol (3M)
515.94K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
23.88B
+26.3%
FY2026
Net Income
5.52B
+11.1%
FY2026
Gross Margin
37.76%
-4.6pp
FY2026
Operating Margin
24.71%
-3.1pp
FY2026
Operating Cash Flow
3.8B
+3.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 23.88B | 18.91B | 11.25B | 13.8B | 11.57B |
| JPY | 14.86B | 10.89B | 7.16B | 8.22B | 6.74B |
| JPY | 9.02B | 8.01B | 4.09B | 5.58B | 4.84B |
| JPY | 5.9B | 5.26B | 1.95B | 3.5B | 2.98B |
| JPY | 7.09B | 6.58B | 3.28B | 6.19B | 5.29B |
| JPY | 1.57B | 1.62B | 806.08M | 1.35B | 1.2B |
| JPY | 5.52B | 4.96B | 2.47B | 4.83B | 4.1B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 4.27B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.